Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes

Elaine Ku; Charles E. McCulloch; Lesley A. Inker; Hocine Tighiouart; Franz Schaefer; Elke Wühl; Piero Ruggenenti; Giuseppe Remuzzi; Barbara Grimes; Mark J. Sarnak

doi:10.1681/asn.0000000000000072

Abstract

1 min read

This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2023_02_27_JASN0000000000000060.mp3.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2025

Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN

Malak Ghaddar, Fernando Caravaca‐Fontán, Manuel Praga, Gema Fernández‐Juárez, Hannah J. Lomax-Browne, H. Terence Cook, Erica Daina, Marina Noris, Giuseppe Remuzzi, Dilshani Induruwage, Bingyue Zhu, Matthew C. Pickering, Sean J. Barbour

Article2017

Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation

Yanish Purmah, Marco Proietti, Cécile Laroche, Michał Mazurek, Dimitrios K. Tahmatzidis, Giuseppe Boriani, Salvatore Novo, Professor Gregory Lip

Letter2020

In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling

Alena Shantsila, Professor Gregory Lip

Letter2019

Reducing Risk of Adverse Cardiovascular and Renal Outcomes for Patients with Atrial Fibrillation and Type 2 Diabetes

Stephanie L. Harrison, Deirdre A. Lane, Professor Gregory Lip

Article2023

Stroke–heart syndrome: mechanisms, risk factors, and adverse cardiovascular events

Benjamin J. R. Buckley, Stephanie L. Harrison, Deirdre A. Lane, Andrew Hill, Professor Gregory Lip